In January 2011, Boots Retail Ireland Ltd announced that it would begin supplying emergency contraception without prescription. This was due to a provision found in the amendment to legislation in 2005 relating to emergency contraception, which states that emergency contraception can be offered by "qualified medical professionals" under protocols set out by a medical professional such as a doctor. Boots stores began offering the morning after pill, Levonelle, one of two products available in...
Euromonitor International's Emergency Contraception in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Emergency Contraception in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Emergency Contraception market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2011
Table 2 Sales of Emergency Contraception: % Value Growth 2011
Table 3 Emergency Contraception Company Shares by Value 2007-2011
Table 4 Emergency Contraception Brand Shares by Value 2008-2011
Executive Summary
Consumer Health Remains Positive
New Guidance for OTC Paediatric Cough/cold Remedies for Children Under Six
Government Cuts Encourage OTC Sales
Pharmacy-led Sales Dominate Channels
Forecast Performance Expected To Be Muted
Key Trends and Development
Difficult Economic Conditions Persist
Your Health Is Your Wealth
Cost Cutting May Lead To Increased Switching
Value Remains Key for Consumers
Market Indicators
Table 5 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 6 Life Expectancy at Birth 2006-2011
Market Data
Table 7 Sales of Consumer Health by Category: Value 2006-2011
Table 8 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 9 Consumer Health Company Shares 2007-2011
Table 10 Consumer Health Brand Shares 2008-2011
Table 11 Penetration of Private Label by Category 2006-2011
Table 12 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 13 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 14 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 15 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Prescription-only Classification
Controlled Drugs
OTC Consumer Health Products
Restrictions on the Sale of Acetaminophen Products
Restrictions on the Sale of Codeine Products
De-listing and De-reimbursement
Switching and Reimbursable Status
Advertising
Manufacturers Seek Greater Freedom in Advertising Prescription-only Products
Self-regulation
Packaging and Labelling
Distribution
Distance Selling Remains Prohibited, While Imports for Personal Use Remain Legal
Vitamins and Dietary Supplements Registration and Classification
Restrictions on the Sale of Products Containing Vitamin Or Mineral Ingredients
EU Legislation
Self-medication/self-care and Preventative Medicine
Generics
Switches
Summary 1 OTC - Switches 2009-2011
Sources
Summary 2 Research Sources
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2011
Table 2 Sales of Emergency Contraception: % Value Growth 2011
Table 3 Emergency Contraception Company Shares by Value 2007-2011
Table 4 Emergency Contraception Brand Shares by Value 2008-2011
Executive Summary
Consumer Health Remains Positive
New Guidance for OTC Paediatric Cough/cold Remedies for Children Under Six
Government Cuts Encourage OTC Sales
Pharmacy-led Sales Dominate Channels
Forecast Performance Expected To Be Muted
Key Trends and Development
Difficult Economic Conditions Persist
Your Health Is Your Wealth
Cost Cutting May Lead To Increased Switching
Value Remains Key for Consumers
Market Indicators
Table 5 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 6 Life Expectancy at Birth 2006-2011
Market Data
Table 7 Sales of Consumer Health by Category: Value 2006-2011
Table 8 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 9 Consumer Health Company Shares 2007-2011
Table 10 Consumer Health Brand Shares 2008-2011
Table 11 Penetration of Private Label by Category 2006-2011
Table 12 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 13 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 14 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 15 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Prescription-only Classification
Controlled Drugs
OTC Consumer Health Products
Restrictions on the Sale of Acetaminophen Products
Restrictions on the Sale of Codeine Products
De-listing and De-reimbursement
Switching and Reimbursable Status
Advertising
Manufacturers Seek Greater Freedom in Advertising Prescription-only Products
Self-regulation
Packaging and Labelling
Distribution
Distance Selling Remains Prohibited, While Imports for Personal Use Remain Legal
Vitamins and Dietary Supplements Registration and Classification
Restrictions on the Sale of Products Containing Vitamin Or Mineral Ingredients
EU Legislation
Self-medication/self-care and Preventative Medicine
Generics
Switches
Summary 1 OTC - Switches 2009-2011
Sources
Summary 2 Research Sources
